Results 181 to 190 of about 42,721 (245)

Paclitaxel-induced germline DNA-damage signatures independent of mismatch repair in <i>C. elegans</i>. [PDF]

Front Pharmacol
Hong Y, Liu Z, Kim HM.
europepmc   +1 more source

Mismatch repair protein imbalance in head and neck squamous cell carcinoma: associations with clinical features and survival. [PDF]

Ther Adv Med Oncol
Yang C, Du M, Liu L, Cai S, Hu W, Yan S, Li M, Gao X, Yang S, Zheng L, Liao W, Song M, Chen S.   +12 more
europepmc   +1 more source

Predictive biomarkers of response to immune checkpoint inhibitors in mismatch repair-deficient endometrial cancer. [PDF]

Ther Adv Med Oncol
Grau Béjar JF, Yaniz Galende E, Genestie C, Blanc-Durand F, Le Formal A, Rouleau É, Leary A.   +6 more
europepmc   +1 more source

Discordant p53 and BRG1 expression in synchronous low-grade uterine endometrioid carcinoma and SMARCA4-deficient ovarian undifferentiated carcinoma: a case report. [PDF]

BMC Womens Health
Sun Y, Sun J, Xie Y, Wang Y, Ma R, Liu Z, Xu L, Yao S, Yu M, Shi W.   +9 more
europepmc   +1 more source

Case Report: Successful treatment of mismatch repair-deficient cervical esophageal adenocarcinoma with immune checkpoint inhibition. [PDF]

Front Oncol
Dou A, Jin CJ, Maziak D, Gilbert S, Sim J, Leung E, Rushton M.   +6 more
europepmc   +1 more source

Hereditary Endometrial Cancer: Lynch Syndrome, Mismatch Repair Deficiency, and Emerging Genetic Predispositions-A Comprehensive Review with Clinical and Laboratory Guidelines. [PDF]

Int J Mol Sci
Kluk A, Gryczka H, Braszka M, Ałtyn R, Markiewicz H, Ślężak JK, Dwojak E, Czerniak J, Zieliński P, Płachno BJ, Dobosz P.   +10 more
europepmc   +1 more source

Clinical Discovery and Molecular Analysis of Two Novel MSH2 Gene Mutations (p.Ala771Gly and p.Val797Gly) in Saudi Colorectal Cancer Patients: Potential Implications for Tumorigenesis. [PDF]

Health Sci Rep
Rasool M, Haque A, Alharthi M, Ali T, Karim S, Mira LS, Al-Abbasi F, Aljiffry M, Ghunaim M, Sibiany A, Pushparaj PN.   +10 more
europepmc   +1 more source

The Keynote-177 Randomized Controlled Trial of First-line PD-1 Blockade for Microsatellite-High or Mismatch Repair-Deficient Advanced Colorectal Cancer: Potential Consequences of the Cross-Over Trial Design and Related Issues. [PDF]

Cancer Med
Gerritse SL, van Meerten E, Duits AJ, Schnog JB.   +3 more
europepmc   +1 more source

Is Male Infertility an Early Warning of More Serious Diseases?

Endocrinology
Lamb DJ.
europepmc   +1 more source